DarioHealth

$26.60
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.37 (-1.37%) Today
$0.00 (0.00%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell DarioHealth and other stocks, options, and ETFs commission-free!

About DRIO

DarioHealth Corp. Common Stock, also called DarioHealth, is a digital therapeutics company, which engages in the research, development, and sale of pharmaceutical products. It offers a monitoring device, mobile application, and data services for diabetes management. Its solutions include MyDario, Daro Engage, and Dario Intelligence. The company was founded by Oren Fuerst, Shoshana Friedman, David Weintraub, Dov Oppenheim, and Shilo Ben Zeev on August 11, 2011 and is headquartered in Caesarea, Israel. The listed name for DRIO is DarioHealth Corp. Common Stock.

CEO
Erez Raphael
Employees
72
Headquarters
Caesarea, Tel Aviv
Founded
2011
Market Cap
283.86M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
300.46K
High Today
$27.65
Low Today
$24.10
Open Price
$27.19
Volume
178.16K
52 Week High
$31.85
52 Week Low
$3.02

DRIO Earnings

-$1.57
-$1.05
-$0.52
-$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Mar 16, Pre-Market

You May Also Like

BNTGY
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure